D.E. Shaw & Co’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2M Sell
798,290
-562,635
-41% -$9.27M 0.01% 1606
2026
Q1
$22.2M Sell
1,360,925
-850,973
-38% -$13.3M 0.01% 1089
2025
Q4
$32.8M Buy
2,211,898
+353,697
+19% +$5M 0.02% 941
2025
Q3
$23.9M Buy
1,858,201
+1,114,699
+150% +$14.9M 0.01% 1064
2025
Q2
$11.3M Buy
743,502
+547,478
+279% +$8.54M 0.01% 1401
2025
Q1
$3.27M Buy
196,024
+146,694
+297% +$2.7M ﹤0.01% 2223
2024
Q4
$930K Sell
49,330
-37,644
-43% -$726K ﹤0.01% 3244
2024
Q3
$1.63M Sell
86,974
-142,663
-62% -$2.73M ﹤0.01% 2875
2024
Q2
$4.34M Buy
229,637
+25,245
+12% +$431K ﹤0.01% 1962
2024
Q1
$3.32M Sell
204,392
-113,324
-36% -$1.66M ﹤0.01% 2232
2023
Q4
$4.02M Buy
317,716
+256,446
+419% +$3.24M ﹤0.01% 2086
2023
Q3
$834K Buy
+61,270
New +$946K ﹤0.01% 3161
2023
Q2
Sell
-29,100
Closed -$405K 4514
2023
Q1
$405K Buy
29,100
+3,411
+13% +$50.2K ﹤0.01% 3651
2022
Q4
$344K Sell
25,689
-3,582
-12% -$46.3K ﹤0.01% 4034
2022
Q3
$349K Sell
29,271
-143,541
-83% -$2.04M ﹤0.01% 4236
2022
Q2
$2.2M Sell
172,812
-423,612
-71% -$5.44M ﹤0.01% 2980
2022
Q1
$7.71M Buy
596,424
+422,209
+242% +$5.58M 0.01% 1854
2021
Q4
$2.76M Sell
174,215
-444
-0.3% -$7.58K ﹤0.01% 3050
2021
Q3
$3.4M Sell
174,659
-187,254
-52% -$3.72M ﹤0.01% 2493
2021
Q2
$8.24M Buy
361,913
+32,557
+10% +$676K 0.01% 1659
2021
Q1
$6.05M Buy
329,356
+133,071
+68% +$2.18M 0.01% 1713
2020
Q4
$2.92M Sell
196,285
-176,133
-47% -$2.3M ﹤0.01% 2295
2020
Q3
$4.18M Sell
372,418
-445,657
-54% -$4.39M ﹤0.01% 1827
2020
Q2
$6.49M Sell
818,075
-214,915
-21% -$1.78M 0.01% 1469
2020
Q1
$8.35M Sell
1,032,990
-511,614
-33% -$6.08M 0.01% 1100
2019
Q4
$19.4M Sell
1,544,604
-454,911
-23% -$4.9M 0.02% 836
2019
Q3
$17.9M Buy
1,999,515
+27,246
+1% +$238K 0.02% 832
2019
Q2
$16.9M Sell
1,972,269
-210,159
-10% -$1.66M 0.02% 838
2019
Q1
$16.6M Buy
2,182,428
+1,229,123
+129% +$9.88M 0.02% 816
2018
Q4
$7.88M Buy
953,305
+854,326
+863% +$8.17M 0.01% 1240
2018
Q3
$981K Sell
98,979
-119,879
-55% -$1.24M ﹤0.01% 2714
2018
Q2
$2.14M Sell
218,858
-93,245
-30% -$916K ﹤0.01% 2177
2018
Q1
$2.9M Buy
312,103
+224,459
+256% +$2.14M ﹤0.01% 1773
2017
Q4
$833K Buy
87,644
+54,073
+161% +$517K ﹤0.01% 2695
2017
Q3
$347K Buy
33,571
+5,566
+20% +$51.4K ﹤0.01% 3083
2017
Q2
$232K Sell
28,005
-208,353
-88% -$1.56M ﹤0.01% 3138
2017
Q1
$1.7M Buy
+236,358
New +$1.71M ﹤0.01% 1945
2016
Q2
Sell
-87,423
Closed -$556K 3508
2016
Q1
$556K Buy
+87,423
New +$469K ﹤0.01% 2729
2015
Q3
Sell
-30,847
Closed -$269K 3878
2015
Q2
$269K Sell
30,847
-89,518
-74% -$752K ﹤0.01% 3460
2015
Q1
$962K Sell
120,365
-885,652
-88% -$6.62M ﹤0.01% 2585
2014
Q4
$7.8M Sell
1,006,017
-93,773
-9% -$684K 0.01% 1265
2014
Q3
$7.13M Sell
1,099,790
-880,057
-44% -$6.8M 0.01% 1317
2014
Q2
$16.6M Buy
1,979,847
+1,097,326
+124% +$8.51M 0.02% 800
2014
Q1
$5.92M Buy
882,521
+450,227
+104% +$2.73M 0.01% 1449
2013
Q4
$2.7M Sell
432,294
-543,854
-56% -$2.66M ﹤0.01% 2233
2013
Q3
$4.24M Buy
976,148
+234,138
+32% +$1.07M 0.01% 1755
2013
Q2
$3.28M Buy
+742,010
New +$3.29M 0.01% 1676

Other funds holding SEM

D.E. Shaw & Co's SEM Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Select Medical (SEM) stake by 41% in Q2 2026, selling an estimated $9.27M and leaving 798,290 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #1606.

D.E. Shaw & Co first reported a position in SEM in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.8M in Q4 2025. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • D.E. Shaw & Co held 798,290 shares of Select Medical worth $13.2M as of Q2 2026.
  • D.E. Shaw & Co sold 562,635 Select Medical shares in Q2 2026, an estimated $9.27M.
  • Select Medical made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1606 holding.
  • D.E. Shaw & Co first reported a position in Select Medical in Q2 2013 and has held it in 47 quarters since.
  • D.E. Shaw & Co's Select Medical position peaked at $32.8M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.